[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYLGLUTAMYL]-GAMMA-SARCOSINE-ESTER;ISOMER-#1
Compound with spectra: 1 NMR
![[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYLGLUTAMYL]-GAMMA-SARCOSINE-ESTER;ISOMER-#1](/api/compound/ATY8QkYiOCY.png?ph=true&h=300&w=458 "[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYLGLUTAMYL]-GAMMA-SARCOSINE-ESTER;ISOMER-#1")
| SpectraBase Compound ID | ATY8QkYiOCY |
|---|---|
| InChI | InChI=1S/C14H24N2O7/c1-14(2,3)23-13(21)15-9(12(20)22-5)6-7-10(17)16(4)8-11(18)19/h9H,6-8H2,1-5H3,(H,15,21)(H,18,19)/t9-/m0/s1 |
| InChIKey | DOZSDBYBKHSJCD-VIFPVBQESA-N |
| Mol Weight | 332.35 g/mol |
| Molecular Formula | C14H24N2O7 |
| Exact Mass | 332.158351 g/mol |
| Enantiomer InChIKey | DOZSDBYBKHSJCD-SECBINFHSA-N |
| Racemate InChIKey | DOZSDBYBKHSJCD-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
ALPHA-METHYL-GAMMA-BENZYL-(2R)-N-(TERT.-BUTOXYCARBONYL)-GLUTAMATE
(S,E)-4-ETHOXY-4-OXOBUT-2-ENYL_5-AMINO-2-(TERT.-BUTOXYCARBONYLAMINO)-5-OXOPENTANOATE
(2R)-2-([(TERT.-BUTYLOXY)-CARBONYL]-AMINO)-5-OXO-PHENYL-PENTANOIC-ACID,METHYLESTER
Boc-D-Glu-OBzl
(S)-2-TERT.-BUTOXYCARBONYLAMINO-5-OXODECA-6-YNOIC-ACID-TERT.-BUTYLESTER
Benzyl (2S)-2-tert-Butoxycarbonylamino-5-oxohexanoate
Benzyl 2(S)-[(tert-Butoxycarbonyl)amino]-5-methylhex-5-enoate
DIBENZYL-TRANS-2,9-BIS-(TERT.-BUTOXYCARBONYLAMINO)-DEC-5-ENEDIOATE
DIBENZYL-CIS-2,9-BIS-(TERT.-BUTOXYCARBONYLAMINO)-DEC-5-ENEDIOATE
| Title | Journal or Book | Year |
|---|---|---|
| Design and preparation of serine–threonine protein phosphatase inhibitors based upon the nodularin and microcystin toxin structures: Part 1. Evaluation of key inhibitory features and synthesis of a rationally stripped-down nodularin macrocycle | Journal of the Chemical Society, Perkin Transactions 1 | 1997 |